FluMist approved for self-administration in the US - astrazeneca.com
WEB4 days ago · FluMist, a needle-free nasal spray, was approved to be self-administered by adults up to 49 years of age or administered by a parent/caregiver to individuals 2-17 years of age. 1. The approval by the US Food and Drug Administration (FDA) was based on a comprehensive submission, which included results from …
FDA Approves Nasal Spray Influenza Vaccine for Self- or Caregiver ...
WEB4 days ago · FluMist is approved for the prevention of influenza disease caused by influenza virus subtypes A and B in individuals 2 through 49 years of age. FluMist is sprayed into the nose and has been used ...
FDA approves first flu vaccine that can be self-administered at …
WEB4 days ago · Link Copied! The FDA approved FluMist as the first flu vaccine that can be self-administered at home. Sarah Silbiger/Getty Images. The US Food and Drug Administration on Friday approved the first ...
FDA approves AstraZeneca's FluMist for self-administration
WEB2 days ago · The US Food and Drug Administration (FDA) has approved AstraZeneca ‘s FluMist, a needle-free nasal spray influenza vaccine for self-administration. The approval makes FluMist the only flu vaccine in the US that can be self-administered by adults up to 49 years or given by a caregiver to people aged two to 17 years.
Nasal Spray Flu Vaccine FluMist Gets FDA Approval for Home Use
WEB12 hours ago · A home version of the nasal flu vaccine FluMist was just approved by the U.S. Food and Drug Administration (FDA) for people ages 2 through 49. Studies have shown nasal spray delivery of the flu ...
US FDA approves AstraZeneca's flu vaccine for self-administration
WEB4 days ago · Sept 20 (Reuters) - The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's (AZN.L), opens new tab nasal spray flu vaccine for self-administration, making it the first ...
US Food and Drug Administration accepts for review AstraZeneca…
WEBOct 24, 2023 · AstraZeneca’s Supplemental Biologics License Application (sBLA) for the approval of a self- or caregiver-administered option for FluMist Quadrivalent, a needle-free nasal spray, has been accepted for review by the US Food and Drug Administration (FDA). If approved, FluMist will be the first flu vaccine available to be self-administered by eligible patients or administered by caregivers ...
FDA approves first self-administered flu vaccine spray - CBS News
WEB4 days ago · The FDA says patients will still need to get a prescription for the vaccine from a health care provider. AstraZeneca says it plans to sell FluMist directly to patients through an online...
FDA approves ‘FluMist,' says no healthcare provider needed
WEB5 days ago · The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for self-administration, making it the first of its kind. FluMist is the first vaccine to ...
FDA Approves First Self-Administered Nasal Spray Flu Vaccine
WEB1 day ago · September 23, 2024. FDA Approves First Self-Administered Nasal Spray Flu Vaccine. Author (s): Brooke McCormick. The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to ...
Skip to content